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Abstract
Objectives Phenocopy frontotemporal dementia (phFTD) is a
rare and poorly understood clinical syndrome. PhFTD shows
core behavioural variant FTD (bvFTD) symptoms without asso-
ciated cognitive deficits and brain abnormalities on conventional
MRI and without progression. In contrast to phFTD, functional
connectivity and white matter (WM) microstructural abnormali-
ties have been observed in bvFTD. We hypothesise that
phFTD belongs to the same disease spectrum as bvFTD
and investigated whether functional connectivity and mi-
crostructural WM changes similar to bvFTD are present in
phFTD.
Methods Seven phFTD patients without progression or alterna-
tive psychiatric diagnosis, 12 bvFTD patients and 17 controls
underwent resting state functional MRI (rs-fMRI) and diffusion
tensor imaging (DTI). Default mode network (DMN) connectiv-
ity and WM measures were compared between groups.
Results PhFTD showed subtly increased DMN connectivity
and subtle microstructural changes in frontal WM tracts.
BvFTD showed abnormalities in similar regions as phFTD,
but had lower increased DMN connectivity and more exten-
sive microstructural WM changes.
Conclusions Our findings can be interpreted as neuropatho-
logical changes in phFTD and are in support of the hypothesis
that phFTD and bvFTD may belong to the same disease spec-
trum. Advanced MRI techniques, objectively identifying
brain abnormalities, would therefore be potentially suited to
improve the diagnosis of phFTD.
Key points
• PhFTD shows brain abnormalities that are similar to
bvFTD.
• PhFTD shows increased functional connectivity in the pari-
etal default mode network.
• PhFTD shows microstructural white matter abnormalities in
the frontal lobe.
• We hypothesise phFTD and bvFTD may belong to the same
disease spectrum.
Keywords Frontotemporal dementia . Diffusion tensor
imaging . Functional magnetic resonance imaging .White
matter . Diagnosis
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Introduction
Phenocopy (or nonprogressive) frontotemporal dementia
(phFTD) is a rare and poorly understood syndrome, which
was only recently described by Davies et al. 2006 [1] in a
subgroup of behavioural variant FTD (bvFTD) patients who
had a better prognosis than expected.
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PhFTD symptomatology is very similar to that of
bvFTD, but some aspects of phFTD are essentially dif-
ferent. In phFTD, core bvFTD symptoms, such as apa-
thy, behavioural disinhibition and loss of insight [2], are
generally not accompanied by cognitive and brain ab-
normalities as is the case in bvFTD. PhFTD patients
show a cognitive profile that ranges from normal to
suggesting FTD [3–6] and have a relatively intact per-
formance of daily living activities (ADL) [2, 6]. These
clinical features in phFTD appear stable over time,
whereas in bvFTD patients rapid progression of cogni-
tive deficits is evident [1, 6–8]. On conventional
(structural) magnetic resonance imaging (MRI), phFTD
patients show no or only borderline abnormalities [1, 8]
in the frontal and temporal regions, which are typically
affected in bvFTD [9]. Positron emission tomography
(PET) does not show the frontal hypometabolism that
is observed in bvFTD [10]. As bvFTD patients may
initially also present without structural MRI abnormali-
ties, early stage distinction between phFTD and bvFTD
may be difficult.
A pathophysiological explanation for phFTD symp-
tomatology is currently unavailable. Patients often re-
main undiagnosed or receive an alternative psychiatric
diagnosis. Additionally, they are occasionally found to
be C9orf72 mutation carriers [11]. It is therefore of im-
portance to investigate the presence of possible brain
abnormalities underlying their symptoms using more ad-
vanced MRI techniques such as resting state functional
MRI (rs-fMRI) and diffusion tensor imaging (DTI).
These techniques measure subtle brain changes so far left
unexplored by looking at functional connectivity and mi-
crostructural white matter (WM). A well-defined network
showing functional abnormalities in bvFTD is the default
mode network (DMN). In bvFTD, parietal regions of the
DMN show increased connectivity [12, 13]. Frontal
DMN connectivity changes are more ambiguous, found
to be either increased [14] or decreased [12]. Such func-
tional changes are thought to precede grey matter atro-
phy appearing at the later stages of bvFTD [12, 15]. WM
abnormalities in bvFTD are found mainly in frontal and
temporal areas such as the uncinate fasciculus (UF), cin-
gulum and genu of the corpus callosum (CC) [16].
Similar regions are found to be already affected in
asymptomatic FTD mutation carriers [15].
As phFTD patients present with behavioural symptoms
similar to bvFTD, we hypothesise that phFTD and bvFTD
may belong to the same disease spectrum. This study investi-
gates whether phFTD patients have underlying brain abnor-
malities that are similar to those seen in bvFTD patients: func-
tional brain abnormalities expressed as DMN connectivity
changes and microstructural WM abnormalities expressed as
diffusion changes.
Methods
Participants
All patients were recruited in the Alzheimer Centre Southwest
Netherlands. PhFTD patients (aged 40-75 years) with promi-
nent behavioural changes interfering with social functioning,
consisting of disinhibition and/or apathy and/or stereotypy; no
reported progression 1 year after initial routine diagnostic
workup, and bvFTD patients (aged 45-70 years) with a diag-
nosis of bvFTD [17]; a clinical dementia rating scale score of
≤1; and a Mini-Mental State Examination [18] (MMSE) score
of ≥ 20 were included in the study.
Patients with other neurological disorders, past or current
substance abuse or other psychiatric diagnosis were excluded.
PhFTD patients with a diagnosis of dementia and missing
heteroanamnesis and bvFTD patients with a different cause
of dementia were also excluded.
Healthy controls (aged 60-70 years), without neurological
or psychiatric history, were recruited through advertisement.
They were matched for gender with phFTD patients and for
age with all patients.
The study was approved by the local medical ethics com-
mittee. All participants gave written informed consent.
Psychiatric, neuropsychological and genetic mutation
assessment
PhFTD patients underwent full psychiatric assessment as part
of this study to exclude alternative diagnoses. Additionally,
their DNAwas tested for the C9orf72 mutation.
All participants underwent a full neuropsychological as-
sessment and an MMSE [18]. Six phFTD patients had a cog-
nitive profile suggestive of FTD, but showed no progression
relative to previous neuropsychological testing consistent with
the phFTD criteria. One phFTD patient had a normal cogni-
tive profile. Mean interval between current and first neuropsy-
chological testing was 36 months (range: 8-71 months). The
cognitive profile was consistent with bvFTD for bvFTD pa-
tients and normal for controls.
Image acquisition
Scanning was performed on two 3T GE Discovery MR750
systems (GE Healthcare, Milwaukee, WI, US) with identical
protocols. PhFTD patients and 12 controls were scanned on
one and bvFTD patients and 8 controls on the other scanner.
All participants underwent a high-resolution three-dimension-
al (3D) inversion recovery (IR) fast spoiled gradient echo
(FSPGR) T1-weighted image for anatomical reference and a
functional gradient echo echo planar imaging (EPI) and DTI
spin echo EPI with full coverage of the supratentorial brain
(Table 1). During the functional scan participants were
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instructed to focus on a fixation cross, to think of nothing in
particular and to stay awake.
Structural MRI analysis
Whole-brain grey matter (GM) volume was calculated for
each participant according to the methods described in Bron
et al. 2014 [19]. For each participant, whole-brain GM volume
was divided by their individual intracranial volume (ICV) to
correct for head size (expressed as % ICV) [20–22] and re-
ferred to as normalised GM (nGM). These values (%ICV)
were then averaged per group, resulting in a mean nGM vol-
ume expressed as %ICV. These group means were then com-
pared between groups using a one-way ANOVA and post-hoc
Bonferroni tests (SPSS21, USA).
Rs-fMRI analysis
Rs-fMRI data were analysed using FMRIB Software library
(FSL4.1.9, UK) (see supplement section 1 for more detail). The
brain was extracted using the Brain Extraction Tool (BET) [23].
Then, MELODIC independent component analysis was used for
pre-processing of the functional data and establishing the DMN
component. Due to the small sample size, only one network of
interest could be investigated. The DMN was chosen as it is a
well-defined functional network showing functional abnormali-
ties in bvFTD, allowing for meaningful comparison between
phFTD and bvFTD. Hereafter, the participant-specific DMN
was identified using dual regression [24]. Subsequently,
Randomize [25] was used to assess between-group DMN
connectivity differences using a one-way ANCOVA with three
groups (phFTD≠bvFTD≠controls) and GMvolume as covariate.
Main effects were investigated and six t-contrasts (phFTD>HC,
HC>phFTD, bvFTD>HC, HC>bvFTD, phFTD>bvFTD,
bvFTD>phFTD) were constructed to assess post-hoc between-
group differences.
Cluster was used to extract cluster information. Results [p-
corrected < 0.05, cluster size (k) ≥ 1; puncorrected <0.05, k ≥ 20]
were visualised using FSLview. Structural atlases implement-
ed in FSLView were used to anatomically identify the DMN
regions.
DTI analysis
Data were corrected for motion, eddy currents and EPI distor-
tions using ExploreDTI [26]. Further analyses were performed
with FSL (5.0.2.2, UK) (see supplement section 1 for more
detail). BET [23] was used to create skull-stripped binary
masks, after which DTIFIT [27] was used to reconstruct dif-
fusion tensors and to create subject images for all WM mea-
sures, i.e. fractional anisotropy (FA), mean diffusivity (MD),
axial diffusivity (AxD) and radial diffusivity (RD). Then, reg-
istration was performed using Tract-Based Spatial Statistics
(TBSS) [28], resulting in subject-specific WM skeletons for
each WM measure. Subsequently, Randomize [25] was used
to assess between-group WM measure differences using a
one-way ANOVA with the same groups and post-hoc t-tests
as in the rs-fMRI analysis.
Cluster was used to extract cluster information. Results (p-
corrected < 0.05, k ≥ 20) were visualised using FSLView. The
WM atlases implemented in FSLView were used to anatomi-
cally identify the WM regions.
Results
Participant and disease characteristics
Data of 7 phFTD patients, 12 bvFTD patients (9 for rs-fMRI
analysis) and 17 controls were used for the current analyses
(Table 2). In total, 9 phFTD patients (all male), 12 bvFTD
patients (7 male) and 20 healthy controls (all male) were orig-
inally included in the study. Two phFTD patients and three
controls were excluded from the analysis (see supplement
section 2). Three bvFTD patients had missing rs-fMRI data.
One phFTD patient’s follow-up was just under 1 year (11
months), for logistical reasons. The clinical diagnosis
phFTD was established based on the clinical profile and lack
of disease progression.
Age [H (2) = 2,23 p > 0.05, Table 2] and the MMSE score
did not differ between groups [H (2) = 5,93, p > 0.05, Table 2].
Table 1 Acquisition parameters
T1w fMRI DTI
FOV (mm) 240 240 240
TE (ms) 3.06 30 84.2*
TR (ms) 7.90 3000 7925
ASSET factor 2 2 2
Flip angle 120° 90° 90°
Acquisition matrix 240 × 240 96 × 96 128 × 128
Slice thickness (mm) 1 3 2.5
Volumes (slices per volume) 1 (176) 200 (44) 28 (59)
Duration (min) 4.41 10.00 3.50
Diffusion-weighted directions n/a n/a 25
Maximum b-value (s/mm2) n/a n/a 1000
TI (ms) 450 n/a n/a
T1w = T1-weighted, fMRI = functional magnetic resonance imaging,
DTI = diffusion tensor imaging, FOV = field of view, TE = echo time,
TR = repetition time, ASSET = array spatial sensitivity encoding tech-
nique, TI = inversion time
*TE for DTI was set to the minimum. This number represents the average
TE. The range of TE was 81.9-90.8 ms
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None of the phFTD patients received an alternative psychi-
atric diagnosis that could explain their behavioural symptoms.
Additionally, none carried the C9orf72 mutation.
Structural MRI
The three groups showed a difference in nGM [H (2) = 16.38,
p < 0.05], with a mean of 0.32 %ICV (SD 0.02) for phFTD,
0.29 %ICV (SD 0.04) for bvFTD and 0.35 %ICV (SD 0.02)
for controls. Compared with controls, both phFTD patients (p
= 0.013) and bvFTD patients (p < 0.001) had lower nGM
volume. nGM volume was not different between phFTD and
bvFTD patients (p = 0.359).
Functional connectivity
PhFTD and bvFTD patients (Fig. 1, supplement Table 1A)
showed connectivity in all regions of the DMN. Controls
showed connectivity in all DMN regions except the right lat-
eral temporal cortex (LTC) (Fig. 1, supplement Table 1A).
PhFTD patients compared with controls showed increased
DMN connectivity in the bilateral medial prefrontal cortex
(mPFC), LTC and inferior parietal lobule (IPL) and in the left
posterior cingulate cortex (PCC)/precuneus (Fig. 2, supple-
ment Table 1B).
BvFTD patients compared with controls showed increased
DMN connectivity in the bilateral mPFC and right LTC and
IPL (Fig. 2, supplement Table 1B) and decreased DMN con-
nectivity in the more posterior right IPL.
PhFTD patients compared with bvFTD patients showed
increased DMN connectivity in the bilateral mPFC and LTC
and right IPL (Fig. 2, supplement Table 1B).
Microstructural WM
PhFTD and bvFTD patients compared with controls showed
decreased FA and increased RD and MDmainly in the frontal
and temporoparietal WM (Fig. 3, supplement Tables 2A-C),
such as the cingulum (both cingulate and hippocampus por-
tion), inferior fronto-occipital fasciculus (IFOF), superior lon-
gitudinal fasciculus (SLF), corpus callosum and uncinate fas-
ciculus. In bvFTD patients in comparison with controls
increased AxD was observed in these regions as well
(Fig. 3, supplement Table 2D).
BvFTD patients compared with phFTD patients showed
decreased FA and increased AxD in frontalWMand increased
MD and RD in frontotemporal WM, mainly in the cingulum
(cingulate portion), IFOF, SLF, corpus callosum and uncinate
fasciculus (Fig. 4, supplement Tables 2A-D).
Discussion
To the best of our knowledge, this is the first study demon-
strating functional connectivity changes and microstructural
WM abnormalities in phFTD. There was increased DMN con-
nectivity in nearly all regions of the DMN and abnormal mi-
crostructural WM in the frontal and temporoparietal lobes.
These changes were similar to the changes observed in
bvFTD, supporting our hypothesis that phFTD may belong
to the same disease spectrum as bvFTD. Specifically,
bvFTD also showed higher connectivity in DMN regions,
but to a lesser extent than in phFTD, and microstructural
WM abnormalities in the frontal and temporoparietal lobes,
but more pronounced than in phFTD.
DMN connectivity was increased, albeit to a moderate ex-
tent, in both phFTD and bvFTD. As there are overt behaviour-
al symptoms in phFTD, as well as frequent neuropsycholog-
ical abnormalities, it is not surprising to observe functional
brain abnormalities. Increased functional connectivity reflects
changes in neuronal activity becoming more congruent be-
tween regions. This may point to a brain mechanism compen-
sating for early diminished neuronal functioning [29, 30]. The
degree of increased connectivity may reflect the brain’s re-
maining ability of compensation, and in case of advanced
neuronal dysfunctioning, this ability may no longer present,
resulting in decreased connectivity. This theory may explain
why we observe higher connectivity in phFTD than in
bvFTD. As pronounced cortical atrophy is evident in bvFTD
but not in phFTD [1, 8, 9, 31], neuronal dysfunctioning is
likely much more prominent in bvFTD. This means that more
relatively preserved neurons in phFTDmay be able to provide
a better functioning compensational mechanism than in
bvFTD. The observation that the inferior parietal lobule
showed both increased and decreased (depending on its sub-
region) functional connectivity in bvFTD in comparison with
controls is in line with this view. It is plausible that the various
subregions of the inferior parietal lobule are not affected to the
same extent in bvFTD, resulting in decreased functional con-
nectivity in the more affected subregion and in increased func-
tional connectivity in the less affected subregion. Future stud-
ies consisting of a larger patient sample could shed further
light on whether other resting-state networks show similar
functional connectivity changes to the DMN. A network of
particular interest would be the salience network, which is a
Table 2 Demographic characteristics
Group N Mean age (years) Mean MMSE
PhFTD 7 (all male) 63.4 (4.8) 26.6 (1.4)
BvFTD 12 (7 male) 60.2 (7.6) 26.6 (2.8)
Controls 17 (all male) 64.1 (3.3) 28.2 (1.5)
PhFTD = phenocopy FTD, BvFTD = behavioural FTD, N = sample size,
values given as mean (SD), MMSE = Mini-mental State Examination
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frontal functional network known to be affected in bvFTD
[13]. This would allow for further meaningful comparisons
between phFTD and bvFTD.
Frontotemporal and parietal microstructural WM abnor-
malities were observed in both phFTD and bvFTD. In
phFTD, FA was decreased (i.e. there was less directional
diffusion) and RD and MD were increased (i.e. there was
more diffusion, particularly perpendicular to the tract’s axis)
in multiple WM tracts, including the cingulum, UF, IFOF,
genu of the CC and SLF. Damage to theseWM tracts has been
linked to the various cognitive functions typically affected in
bvFTD. Loss of behavioural control (e.g. disinhibition) has
Fig. 1 Mean default mode
network (DMN) connectivity [p <
0.05, not corrected for multiple
comparisons, but Bonferroni
corrected (p < 0.05) for multiple
contrasts; k≥20] in phenocopy
frontotemporal dementia
(phFTD), behavioural variant
FTD (bvFTD) and controls
Fig. 2 Post-hoc t-test comparisons (phFTD>bvFTD, phFTD>controls,
bvFTD>controls) showing between-group DMNconnectivity differences
(p < 0.05, not corrected for multiple comparisons, but within the
constraints of the omnibus f-test (p < 0.05, Bonferroni corrected for
multiple contrasts); k ≥ 20).DMN = default mode network, phFTD =
phenocopy frontotemporal dementia, bvFTD = behavioural variant FTD
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been related to diffusion changes in the UF, forceps minor and
cingulum [32, 33]. Additionally, abnormalities in executive
functioning, visuo-spatial attention, working memory and ap-
athy have also been linked with diffusivity changes in the
cingulum [34, 35]. Interestingly, RD changes in these tracts
were less pronounced than FA changes, which may be ex-
plained by FA being a composite measure of both RD and
AxD (i.e. diffusion along the tract’s main axis), and therefore
more sensitive to subtle myelin and/or axonal changes,
reflected by changes in RD [36] and AxD [37] respectively.
In phFTD, AxD abnormalities were not observed, which may
be explained bymyelin damage only, without axonal injury. In
bvFTD,WMchanges weremore pronounced and widespread,
with lower FA and higher MD, RD and AxD than in phFTD.
Hence, here we show an association in phFTD, similar to
bvFTD, between symptomatology and damage to the
frontotemporal and parietalWM tracts. Additionally, we show
differences possibly reflecting neuropathological changes be-
tween phFTD and bvFTD, with phFTD suggesting myelin
damage only and bvFTD showing more pronounced myelin
and axonal damage.
Previous literature has shown a relationship between mi-
crostructural WM changes and functional connectivity chang-
es [38–40] and proposes that microstructural WM predicts, or
is reflected by, functional connectivity [39, 40]. For example,
the medial prefrontal cortex and posterior cingulate cortex,
core regions of the DMN, are connected through the cingulum
[39]. Cingulum abnormalities such as observed in this study
may have— to a certain extent—disconnected these regions,
reducing the functional connectivity between the anterior and
posterior DMN regions. In support of this idea, there were
more pronounced anterior WM abnormalities in bvFTD that
extended more posteriorly than in phFTD, and both frontal
and parietal functional connectivity were seen to be corre-
spondingly lower. A recent study by Weiler et al. (2014)
[41] observed that higher RD in the cingulum and
parahippocampal bundle (both connecting DMN regions) pre-
dicted reduced performance on measures related to DMN
Fig. 3 Post-hoc t-test of microstructural white matter changes for phFTD
(pcorrected < 0.05; k ≥ 20) and bvFTD (pcorrected < 0.05; k ≥ 20) in
comparison with controls. Lower FA and higher MD, RD and AxD in
comparison with controls are shown in phFTD in red and in bvFTD in
blue. WM regions showing overlapping abnormalities in phFTD and
bvFTD are shown in pink. PhFTD = phenocopy frontotemporal
dementia, bvFTD = behavioural variant frontotemporal dementia, FA =
fractional anisotropy, MD = mean diffusivity, RD = radial diffusivity,
AxD = axial diffusivity
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cognitive functions. We therefore hypothesise that more ad-
vanced abnormalities of WM tracts of the DMN may eventu-
ally lead to a functional decrease in the associated DMN areas
and result in reduced cognitive functioning. As we did not aim
to directly explore such a mechanism, our study design does
not allow for any firm conclusions concerning this mecha-
nism. A longitudinal design employing correlational analyses
is needed to verify this hypothesis.
Overall, phFTD showed functional connectivity and subtle
WM changes, whereas bvFTD showed fewer functional con-
nectivity and more extensive WM changes. Lower overall
cortical GM volume in phFTD patients was observed in this
study using a quantitative method, but was not observed in the
regular clinical diagnostic work-up. This suggests that GM
volume loss is also present in phFTD patients, but at such a
limited degree that it is not clinically detected. These findings
are indicative of incipient degeneration in phFTD. In order to
investigate phFTD without the interference of an alternative
diagnosis we ruled out alternative psychiatric disorders, neu-
ropsychological progression and presence of the C9orf72
mutation. The observed incipient brain changes in this well-
defined population are in favour of the controversial notion
that phFTD and bvFTD may belong to the same disease spec-
trum. PhFTD presents with behavioural, neuropsychological
and, as shown here, also neurodegenerative changes that are
all similar to those observed in bvFTD.
This study has some limitations. First, we were only able to
investigate a small number of phFTD and bvFTD patients,
limiting the statistical power. As a result, rs-fMRI effects, al-
ready expected to be subtle, were only detectable using a rela-
tively lenient statistical threshold and could only be investigated
in one functional network. The sample size is inherent to the
rarity of the phFTD syndrome, together with the application of
strict inclusion and exclusion criteria to avoid inadvertent inclu-
sion of patients with bvFTD or alternative psychiatric disorders.
Second, the bvFTD group was not fully matched for gender
with the phFTD and control group. There is no conclusive
evidence on gender differences in functional connectivity [42]
or microstructural WM. Both higher and lower FA was mea-
sured in the cingulum and in the WM underlying the frontal
Fig. 4 Post-hoc t-test microstructural white matter changes for bvFTD in
comparison with phFTD (pcorrected < 0.05; k ≥ 20). Lower FA and higher
MD, RD and AxD in bvFTD are shown in blue. PhFTD = phenocopy
frontotemporal dementia, bvFTD = behavioural variant FTD, FA =
fractional anisotropy, MD = mean diffusivity, RD = radial diffusivity,
AxD = axial diffusivity
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cortex in men and in women compared with the opposite gen-
der [43]. Given these findings it is not likely that the FA de-
creases observed in this study were driven by gender differ-
ences. Third, the bvFTD group and part of the control group
were scanned on a different scanner, although of identical type
and field strength, and with identical protocols. While a scanner
effect cannot be excluded, both rs-fMRI and DTI have been
shown to be highly reproducible in terms of DMN functional
connectivity and TBSS respectively, even across different scan-
ner platforms and vendors [44, 45]. Moreover, the fact that our
findings in bvFTD are consistent with the previous literature
suggests that the scanner effect is likely to be minimal.
In conclusion, our findings are in support of the hypothesis
that phFTD and bvFTD may belong to the same disease spec-
trum. In phFTD, there are changes in functional connectivity
and microstructural WM that are similar to those found in
bvFTD. Advanced MRI techniques, such as rs-fMRI and
DTI, are therefore potentially suited to improve the diagnosis
of phFTD by identifying such incipient changes. Naturally,
the hypothesis that phFTD and bvFTD may belong to the
same disease spectrum would require confirmation with other
diagnostic tools, such as histopathology. Also, further assess-
ment in a longitudinal study to assess changes over time
would be required, at which our future efforts are aimed.
Our findings could provide a direction for further develop-
ment of MR—or other—diagnostic tools.
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